Clinical Trials Browser

Phase 4 × Neoplasms × Ipilimumab × Clear all

NCT06031233 2026-03-30

MINUTE

Phase 4 Recruiting

Neoplasms

NCT02068196 2023-03-24

Ipi4

Phase 4 Active not recruiting

Melanoma, Neoplasms